What We're Reading: Page 171
Industry reads hand-picked by our editors
Jan 14, 2021
-
Pink Sheet
Woodcock To Be Acting US FDA Commissioner, Leaving Agency in Stable, Capable Hands
-
POLITICO
Officials: Trump's promised $200 drug-discount cards won't happen
-
STAT
Former Merck employee arrested for stealing trade secrets on cancer research
-
Healthcare Dive
Talkspace to go public via SPAC in $1.4B deal
Jan 13, 2021
-
The Wall Street Journal
Cancer Death Rate in U.S. Falls by Largest Yearly Amount on Record
-
POLITICO
FDA fights for independence in Trump administration's final days
-
Evaluate Vantage
Merck & Co buys into Kras
-
The New York Times
Johnson & Johnson Expects Covid Vaccine Results Soon but Lags in Production
Jan 12, 2021
Jan 11, 2021
-
Barron's
Start-Up EQRx, Which Wants to Undersell the Drug Industry, Raises Another $500 Million
-
Reuters
Sanofi buys Kymab for up to $1.5 billion to expand in immunotherapy
-
STAT
FDA advisory panel meetings became "rarer and tougher" in 2020
-
Endpoints News
Editas Medicine's science head Albright leaves for new job just as biotech gets trial clearance for sickle cell therapy
Jan 08, 2021
Jan 07, 2021
-
STAT
Serial biotech entrepreneur John Hood targets deadly lung disease
-
POLITICO
Biden to phase out Operation Warp Speed co-leader
-
Boston Business Journal
Three months after launch, precision medicine startup Scorpion Therapeutics raises $162M
-
Evaluate Vantage
Covid or not, venture financing breaks records
Jan 06, 2021
-
The New York Times
Warning of Shortages, Researchers Look to Stretch Vaccine Supply
-
Medium
The First Pig-to-Human Organ Transplants Could Happen This Year
-
The Guardian
No data to support UK delay of vaccines’ second dose, says WHO
-
Endpoints News
With lessons learned from Vor, Siddhartha Mukherjee takes a different route to target solid tumors with startup Myeloid
Previous
